Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ceva launches wildlife research fund
The Ceva Wildlife Research Fund is funding the final stage of development of a chlamydia vaccine for koalas.
The first endowment fund dedicated to wildlife research.

Ceva has launched Ceva Wildlife Research Fund, a unique endowment fund to finance applied research to preserve the health of wild animals and help control the risk of zoonoses.

The global health company has pledged that the results of research supported by the fund will be visible within a maximum of three to five years.

The Ceva Wildlife Research Fund will support a number of concerns, including research into the control of diseases that occur in wildlife and tracing the origin of outbreaks. The risk of zoonotic diseases is increasing, with 75 per cent of new infectious diseases affecting humans today originating in animals - mainly wild animals.

The fund will also enable applied research to preserve biodiversity. An example of which is Ceva’s collaboration with the University of the Sunshine Coast in Brisbane, funding the final stage of development and associated testing of their chlamydia vaccine for koalas, as well as supporting additional studies to be used in the official registration process of the vaccine.

Australian authorities declared the population of East Coast koalas as a threatened species in February 2022. Their declining population may be due to the destruction of their natural habitat due to fires, increasing urbanisation, as well as chlamydia, which is having a serious impact on their reproduction and long-term survival.

President of Ceva Wildlife Research Fund Marc Prikazsky, said: "Addressing biodiversity in a holistic way is nothing new for Ceva. However, with the creation of this endowment fund, we wanted to create a separate structure to enshrine this activity. Ceva Wildlife Research Fund comes at a crucial time for research in the field. As we face an urgent need to act, we want to provide funds for innovative solutions to prevent, diagnose and treat diseases that can be transmitted from animals to humans, but also to contribute to the preservation of endangered species and to secure safer interactions between wild and farmed animals.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.